A wave of newly published science and analysis from the 2008 International Symposium
on Chylomicrons in Disease (ISCD) raises a warning flag to the global health community
over an overlooked type of cholesterol. It also serves as a call to action towards further
progress that will be featured at the next ISCD conference planned for March 2010.
The science focuses on chylomicrons – a type of cholesterol carrier formed in the
intestine. Because chylomicrons are processed quickly, they are virtually undetected by
common doctor-directed cholesterol tests. Now growing evidence points to chylomicrons
as a major missing puzzle piece in the diagnosis and treatment of metabolic disorders that
give rise to heart disease and stroke, diabetes, chronic obesity and other dangerous health
conditions.